Cardiovascular Safety of Evolocumab: a Systematic Review and Meta-Analysis

Cardiovasc Drugs Ther. 2016 Dec;30(6):645-646. doi: 10.1007/s10557-016-6703-0.
No abstract available

Publication types

  • Editorial
  • Meta-Analysis
  • Review
  • Systematic Review

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Anticholesteremic Agents / therapeutic use*
  • Cholesterol, LDL / blood
  • Humans
  • Hypercholesterolemia / blood
  • Hypercholesterolemia / drug therapy*
  • PCSK9 Inhibitors

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Anticholesteremic Agents
  • Cholesterol, LDL
  • PCSK9 Inhibitors
  • PCSK9 protein, human
  • evolocumab